Postoperative Fatigue and Nausea Related to Choice of Anaesthetic Regimens
NCT ID: NCT01125982
Last Updated: 2014-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
130 participants
INTERVENTIONAL
2010-06-30
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Desflurane
Patients will receive Desflurane to provide sleep during anaesthesia for laparoscopic cholecystectomy. Analgesia will be provided by remifentanil.
Desflurane
Continuous inhalation at 0.7-0.8 MAC (endtidal) during anaesthesia to provide sleep
Propofol
Patients will receive Propofol to provide sleep during anaesthesia for laparoscopic cholecystectomy. Analgesia will be provided by remifentanil.
Propofol
Continuous intravenous infusion at 3-6 µg/mL (Ce - Target Controlled Infusion) during anaesthesia to provide sleep.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Propofol
Continuous intravenous infusion at 3-6 µg/mL (Ce - Target Controlled Infusion) during anaesthesia to provide sleep.
Desflurane
Continuous inhalation at 0.7-0.8 MAC (endtidal) during anaesthesia to provide sleep
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient is able to read and comprehend Norwegian language
* The patient is cognitive adequate and able to fill in survey forms
* The patient has read and signed patient information form
Exclusion Criteria
* Pregnancy or suspected pregnancy
* Breastfeeding women
* Contraindications to use of NSAIDs
* Serious allergic reaction to anaesthetics
* Allergy towards egg, soya or peanuts
* Known or suspected Malignant Hyperthermia or Porphyria
* Fatigue-related diagnosis
* Recently received adjuvant therapy (chemotherapy, radiotherapy)
* Severe chronic pain
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sykehuset Telemark
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Torkjell Nostdahl
MD, Anaesthesiologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Telemark Hospital
Skien, Telemark, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009-017117-30
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
09/15863
Identifier Type: OTHER
Identifier Source: secondary_id
2009/2171(REK)
Identifier Type: -
Identifier Source: org_study_id